Clinical Trial Update: Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the immunogenicity and safety of a serum-free Vero cell–based rabies vaccine for pre-exposure prophylaxis, which is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (Serum-free Vero Cell)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Rabies | Phase 3 | Status: NOT_YET_RECRUITING